| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 63 |
| 1 | PREDNISONE | 13 |
| 2 | HUMAN IMMUNOGLOBULIN G | 12 |
| 3 | METHYLPREDNISOLONE | 12 |
| 4 | PREGABALIN | 11 |
| 5 | METHOTREXATE | 10 |
| 6 | METHOTREXATE SODIUM | 10 |
| 7 | NAPROXEN | 10 |
| 8 | NAPROXEN SODIUM | 10 |
| 9 | TOCILIZUMAB | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRANKINCENSE | 3 | 0.0492 |
| 1 | BELZUTIFAN | 2 | 0.0011 |
| 2 | NELARABINE | 1 | 0.0010 |
| 3 | OCRELIZUMAB | 63 | 0.0010 |
| 4 | NARATRIPTAN | 1 | 0.0007 |
| 5 | POLATUZUMAB VEDOTIN | 6 | 0.0006 |
| 6 | HUMAN IMMUNOGLOBULIN G | 12 | 0.0006 |
| 7 | FERUMOXYTOL | 1 | 0.0005 |
| 8 | BENDAMUSTINE HCL | 6 | 0.0004 |
| 9 | GLOFITAMAB | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 12 | 0.0006 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 3 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 71 | 0.0002 |
| 5 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 6 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 8 | 0.0001 |
| 8 | Potassium Channel Blocker [EPC] | 6 | 0.0001 |
| 9 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |